Faculty

Chris Buesing, MBA, CSSBB
Director, Worker’s Compensation and Workforce Safety
Stormont Vail Health

Maxine Simon, FACHE, CHC, CHPC
Chief Regulatory Officer
NYU Langone Health

Jennifer Hardman, PharmD
Manager, Ambulatory Pharmacy Services
Froedtert & the Medical College of Wisconsin

Kristen Nelson, MHA
Continuous Improvement Specialist
Froedtert & the Medical College of Wisconsin

Michelle Franklin, BSN, MBA, RN, CPHQ, CPPS
Peaks Region Risk and Patient Safety Manager
Intermountain Health

Andrea Owen, BHA, CPPS
Program Manager, Ambulatory Care, Risk & Patient Safety, Peaks Region
Intermountain Health

Jamie Neuhauser, RN
Clinical Outcomes Specialist – Patient Safety
Norman Regional Heath System

Jenny Anderson, MAS, RN, CPHQ
Patient Quality and Safety Officer
Administrative Director of Quality, Performance Improvement, and Patient Safety
Norman Regional Heath System

Tammy Williams, MSN, RN, CPPS
Program Director
Vizient, Inc.

Anthony Guth
Sr. Consulting Director, Intelligence
Sg2

Jaie Lavoie, PharmD, MSHI
AVP, Data Science and Informatics
Vizient, Inc.

Planning committee

Ellen Flynn, RN, MBA, JD
Principal
Vizient, Inc. 

Kathryn Merkeley, MHSA, RN, PMP, CPPS
Program Director
Vizient, Inc. 

Jim Lichauer, PharmD, BCPS, FASHP
Sr. PI Program Director
Vizient, Inc. 

Jay Prystowsky, MD, MBA
Principal
Vizient, Inc.

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Disclosure of Financial Relationships:

Absence of Relevant Financial Relationships

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.

Statement of Content Validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.